Profil
Kenan Turnacioglu is the founder of PointState Capital LP, which was founded in 2011.
He held the title of Vice Chairman at PointState Capital LP.
He is currently the Chairman at Paige.
Ai, Inc. since 2017.
Dr. Turnacioglu has also held former positions as a Director at Stemcentrx, Inc. from 2013 to 2016, as well as a Director at Agensys, Inc. from 2004 to 2007.
He was also a Director at Immunai, Inc., HealthCor Catalio Acquisition Corp., and Nyu Langone Cancer Center from 2010 to 2015.
Additionally, Dr. Turnacioglu worked as an Equity Analyst at Duquesne Capital Management LLC.
He was a General Partner at Catalio Capital Management LP from 2020 to 2021.
Dr. Turnacioglu obtained a doctorate degree from the University of Pennsylvania and an undergraduate degree from Rutgers State University of New Jersey.
Postes actifs de Kenan Turnacioglu
| Sociétés | Poste | Début |
|---|---|---|
Paige.Ai, Inc.
Paige.Ai, Inc. Packaged SoftwareTechnology Services Operates as an AI company specializing in digital pathology | Président | 01/01/2017 |
Anciens postes connus de Kenan Turnacioglu
| Sociétés | Poste | Fin |
|---|---|---|
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Membre du Comité d'Investissement | 31/10/2021 |
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Directeur/Membre du Conseil | 01/01/2016 |
Nyu Langone Cancer Center | Directeur/Membre du Conseil | 01/01/2015 |
Duquesne Capital Management LLC
Duquesne Capital Management LLC Investment ManagersFinance Duquesne Capital Management is a top-down manager that invests in growth-oriented value stocks. The firm looks for market leaders and turnaround stocks. They focus primarily on investments in the stocks of mid-cap and large-cap US companies in the energy minerals, process industries, health technology and electronic technology sectors. Duquesne Capital Management maintains a very high turnover rate. | Analyst-Equity | 31/10/2010 |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines for cancers | Directeur/Membre du Conseil | 01/01/2007 |
Formation de Kenan Turnacioglu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Duquesne Capital Management LLC
Duquesne Capital Management LLC Investment ManagersFinance Duquesne Capital Management is a top-down manager that invests in growth-oriented value stocks. The firm looks for market leaders and turnaround stocks. They focus primarily on investments in the stocks of mid-cap and large-cap US companies in the energy minerals, process industries, health technology and electronic technology sectors. Duquesne Capital Management maintains a very high turnover rate. | Finance |
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines for cancers | Commercial Services |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PointState Capital LP
PointState Capital LP Investment ManagersFinance PointState Capital aims to achieve superior capital appreciation by pursuing multiple investment strategies including, but not limited to long/short equities, global macro, investing in commodity and commodity-related industries, high yield and distressed credit, event-driven/special situations investing, relative value investing and private investments. | Finance |
Paige.Ai, Inc.
Paige.Ai, Inc. Packaged SoftwareTechnology Services Operates as an AI company specializing in digital pathology | Technology Services |
Immunai, Inc.
Immunai, Inc. Packaged SoftwareTechnology Services Develops immune system technology to treat oncology diseases | Technology Services |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Finance |
HealthCor Catalio Acquisition Corp.
HealthCor Catalio Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Nyu Langone Cancer Center |
















